Phase 1Completed
Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects
Effects of THVD-201 on Pharmacokinetics and Pharmacodynamics of Tolterodine in Healthy Subjects
- Sponsor
- TheraVida, Inc. (Industry)
- Enrollment
- 18 enrolled
- Conditions
- Incontinence
- Interventions
- Tolterodine; Pilocarpine; THVD-201; THVD-201; placebo capsule
- Ages
- adults
- Registry
- NCT01036035
Full record on ClinicalTrials.gov
From the registry
THVD-201 is a novel combination of a muscarinic antagonist (tolterodine) and a muscarinic agonist (pilocarpine).
Primary outcomes
- Reductions in stimulated salivary flow (SSF)
History
Last registry update
Study completion
Primary completion
Registered
Started